Remove Healthcare Remove Networking Remove Pharma Remove Pharmaceutical manufacturing
article thumbnail

Bob Harrell

Pharma Marketing Network

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). The post Bob Harrell appeared first on Pharma Marketing Network.

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

When people think about pharma, they often think about “big” pharma: large, faceless corporations. The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We But rare diseases are a particularly important and challenging focus area. Chiesi’s philosophy in action.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. Pharma Manufacturer Solutions. GM of Manufacturer Solutions. Furthermore, it is estimated to reach $6.5 billion in 2030 at a CAGR of 9.2%.

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

In this blog, we take a close look at health equity in oncology trials specifically, assessing how the lack of diversity and inclusion has impacted cancer patients and the pharma industry’s key initiatives to address it. J National Comprehensive Cancer Network. Clarify launched its real-world evidence on health disparities in 2021.

article thumbnail

Ep. 002 – John Mack Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. So, you continue with Pharma Marketing news. Where do you see it going? RJ Lewis (EHS): So, thanks for that question. That’s our vision.

Pharma 52
article thumbnail

Trends in Virtual Collaboration

Impetus Digital

Many of these will discuss the expanding role and capabilities of AI and machine learning in the Pharma space. The new way to engage KOLs at conferences: virtual Ambassador programs To start off the top-5, let’s take a look at how Pharma is shifting the way they engage key opinion leaders (KOLs) at medical congresses and conferences.